Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical Study
- Status
- RECRUITING
- Phase
- PHASE2
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2